title: Vaccines against influenza WHO position paper – November 2012.
mesh_terms: D000368:Aged; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D005260:Female; D006282:Health Personnel; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D007251:Influenza, Human / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D032541:Mass Vaccination / Q000191:economics; D008875:Middle Aged; D011247:Pregnancy; D012307:Risk Factors; D014195:Travel; D014613:Vaccines, Attenuated / Q000009:adverse effects / Q000627:therapeutic use; D015164:Vaccines, Inactivated / Q000009:adverse effects / Q000627:therapeutic use; D014944:World Health Organization
chemical_list: D007252:Influenza Vaccines; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated